- Let's make a deal May 6
There's been a high-stakes reshuffling of the deck in the global pharmaceutical industry, and the latest company to show its hand is Germany's Bayer, which said Tuesday morning that it's purchasing Merck's consumer care unit for $14.2 billion. That means the company that pioneered aspirin — and now also makes Alka-Seltzer, Aleve, and Flintstones vitamins, among other brands — will own Claratin, Afrin, Coppertone, and Dr. Scholl's foot products. But the bigger prize for Bayer, assuming the deal goes through, is that it will be the No. 2 consumer drugmaker in the world, after Johnson & Johnson.- -
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- 13 Urban Outfitters controversies
- This is how the U.S. thinks China could invade Taiwan
- 6 things the happiest families all have in common
- 43 TV shows to watch in 2014
- The science of sex: 4 harsh truths about dating and mating
- Can we lead spiritually fulfilling lives without religion?
- Obama knows he can't really 'defeat' ISIS. Americans need to wake up to that reality, too.
- Surviving a plane crash
- Why you should stop believing in evolution
- Stop freaking out over the West's jihadi tourists
Subscribe to the Week